These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30770432)

  • 1. Validation of an algorithm for identifying MS cases in administrative health claims datasets.
    Culpepper WJ; Marrie RA; Langer-Gould A; Wallin MT; Campbell JD; Nelson LM; Kaye WE; Wagner L; Tremlett H; Chen LH; Leung S; Evans C; Yao S; LaRocca NG;
    Neurology; 2019 Mar; 92(10):e1016-e1028. PubMed ID: 30770432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an algorithm to detect severe MS relapses in administrative health databases.
    Marriott JJ; Chen H; Fransoo R; Marrie RA
    Mult Scler Relat Disord; 2018 Jan; 19():134-139. PubMed ID: 29223870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.
    Al-Sakran L; Marrie RA; Blackburn D; Knox K; Evans C
    BMJ Open; 2019 Nov; 9(11):e033599. PubMed ID: 31772108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of MS in the United States: A population-based estimate using health claims data.
    Wallin MT; Culpepper WJ; Campbell JD; Nelson LM; Langer-Gould A; Marrie RA; Cutter GR; Kaye WE; Wagner L; Tremlett H; Buka SL; Dilokthornsakul P; Topol B; Chen LH; LaRocca NG;
    Neurology; 2019 Mar; 92(10):e1029-e1040. PubMed ID: 30770430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
    Marrie RA; Yu N; Blanchard J; Leung S; Elliott L
    Neurology; 2010 Feb; 74(6):465-71. PubMed ID: 20071664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
    Al-Sakran LH; Marrie RA; Blackburn DF; Knox KB; Evans CD
    Can J Neurol Sci; 2018 May; 45(3):295-303. PubMed ID: 29557321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study.
    Nickel KB; Wallace AE; Warren DK; Ball KE; Mines D; Fraser VJ; Olsen MA
    BMC Health Serv Res; 2016 Aug; 16(a):388. PubMed ID: 27527888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a case definition for epilepsy for use with administrative health data.
    Reid AY; St Germaine-Smith C; Liu M; Sadiq S; Quan H; Wiebe S; Faris P; Dean S; Jetté N
    Epilepsy Res; 2012 Dec; 102(3):173-9. PubMed ID: 22727659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).
    Chan AW; Fung K; Tran JM; Kitchen J; Austin PC; Weinstock MA; Rochon PA
    JAMA Dermatol; 2016 Oct; 152(10):1122-1127. PubMed ID: 27533718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
    Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
    Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
    Widdifield J; Ivers NM; Young J; Green D; Jaakkimainen L; Butt DA; O'Connor P; Hollands S; Tu K
    Mult Scler; 2015 Jul; 21(8):1045-54. PubMed ID: 25392338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis incidence and prevalence in Poland: Data from administrative health claims.
    Wnuk M; Maluchnik M; Perwieniec J; Podwojcic K; Szelag M; Walkiewicz D; Zakrzewski M; Kulakowska A; Brola W; Rejdak K; Slowik A
    Mult Scler Relat Disord; 2021 Oct; 55():103162. PubMed ID: 34332458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis.
    Capkun G; Lahoz R; Verdun E; Song X; Chen W; Korn JR; Dahlke F; Freitas R; Fraeman K; Simeone J; Johnson BH; Nordstrom B
    Curr Med Res Opin; 2015 May; 31(5):1029-39. PubMed ID: 25661016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.
    Widdifield J; Bernatsky S; Paterson JM; Tu K; Ng R; Thorne JC; Pope JE; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1582-91. PubMed ID: 23592598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis prevalence in the United States commercially insured population.
    Dilokthornsakul P; Valuck RJ; Nair KV; Corboy JR; Allen RR; Campbell JD
    Neurology; 2016 Mar; 86(11):1014-21. PubMed ID: 26888980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Patients With Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Healthcare Data.
    Van Le H; Le Truong CT; Kamauu AWC; Holmén J; Fillmore C; Kobayashi MG; Martin C; Sabidó M; Wong SL
    Value Health; 2019 Jan; 22(1):77-84. PubMed ID: 30661637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.
    Lyons J; Desai V; Xu Y; Ridgeway G; Finkle W; Solari P; Sullivan S; Lanes S
    Value Health; 2018 Sep; 21(9):1098-1103. PubMed ID: 30224115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
    Bergvall N; Lahoz R; Reynolds T; Korn JR
    Curr Med Res Opin; 2014 Aug; 30(8):1461-71. PubMed ID: 24754349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.
    Marrie RA; O'Mahony J; Maxwell C; Ling V; Yeh EA; Arnold DL; Bar-Or A; Banwell B;
    Neurology; 2018 Oct; 91(17):e1579-e1590. PubMed ID: 30258022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
    Chung CP; Rohan P; Krishnaswami S; McPheeters ML
    Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.